StockNews.AI
BLMZ
StockNews.AI
7 days

Harrison Global Holdings Signs Strategic International Business Partnership Agreement with Biotree Co., Ltd., the World's First Natural Product Drug Development Company for Metabolic Syndrome

1. Harrison Global partners with Biotree to develop health treatments. 2. This venture may enhance BLMZ's business diversification and market value.

2m saved
Insight
Article

FAQ

Why Bullish?

The partnership with Biotree could offer new revenue streams, similar to past successful collaborations in the health sector that boosted company valuations.

How important is it?

The strategic partnership may significantly diversify BLMZ's portfolio, increasing market attractiveness and valuations.

Why Long Term?

Long-term benefits expected as health and wellness sectors grow, mirroring trends seen in technology and entertainment.

Related Companies

BIOTNVCRISRG
TOKYO, JAPAN / ACCESS Newswire / August 12, 2025 / Harrison Global Holdings Inc. (NASDAQ:BLMZ) ("Harrison Global" or the "Company"), a Japanese audio production, V-Tuber, entertainment, and voice actor management company, announced today that it has signed a strategic international business partnership agreement with Biotree Co., Ltd. ("Biotree"), a Korean firm developing the world's first natural product-based treatment for metabolic syndrome - including diabetes, obesity, hyperlipidemia, and hypertension.

Related News